Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Human Polyclonal SEMA7A Primary Antibody for WB - ABIN1881787
Yamada, Kubo, Takeshita, Harashima, Kawano, Mine, Sagawa, Sugamura, Itoh: Molecular cloning of a glycosylphosphatidylinositol-anchored molecule CDw108. in Journal of immunology (Baltimore, Md. : 1950) 1999
Show all 5 Pubmed References
Human Polyclonal SEMA7A Primary Antibody for CyTOF, FACS - ABIN4900369
Roth, Köhler, Schneider, Granja, Rosenberger: Semaphorin 7A Aggravates Pulmonary Inflammation during Lung Injury. in PLoS ONE 2016
Show all 3 Pubmed References
Human Monoclonal SEMA7A Primary Antibody for FACS, IP - ABIN93946
Suzuki, Okuno, Yamamoto, Pasterkamp, Takegahara, Takamatsu, Kitao, Takagi, Rennert, Kolodkin, Kumanogoh, Kikutani: Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. in Nature 2007
Show all 6 Pubmed References
Human Monoclonal SEMA7A Primary Antibody for FACS, IP - ABIN93945
Pasterkamp, Kolk, Hellemons, Kolodkin: Expression patterns of semaphorin7A and plexinC1 during rat neural development suggest roles in axon guidance and neuronal migration. in BMC developmental biology 2007
Show all 6 Pubmed References
Human Monoclonal SEMA7A Primary Antibody for ELISA, WB - ABIN521933
Peng, Moore, Mathur, Zhou, Sun, Gan, Herazo-Maya, Kaminski, Hu, Pan, Ryu, Osafo-Addo, Homer, Feghali-Bostwick, Fares, Gulati, Hu, Lee, Elias, Herzog: Plexin C1 deficiency permits synaptotagmin 7-mediated macrophage migration and enhances mammalian lung fibrosis. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2016
sema7A is involved in peripheral immunity and central nervous system inflammation in multiple sclerosis pathogenesis.
These findings indicate that Sema7A as a potent activator of T cells and monocytes in the immune response contributes to the inflammation and progression of rheumatoid arthritis
Our results suggest that semaphorin 7a may be novel target for blocking breast tumor progression.
SEMA7A plays a critical role in IgE-mediated neutrophilic airway inflammation
SEMA7A has a role in the development of lung injury
Data suggest that sema7A is involved in the pathogenesis of experimental autoimmune encephalomyelitis, in the modulation of the immune response and in the neurodegeneration that take place in the CNS.
This study demonstrates that Sema7A controls the assembly of actin-based protrusions that drive Dendritic cell migration in response to CCL21 (show CCL21 Antibodies).
Sem7a and its receptors regulate Chi3l1 (show CHI3L1 Antibodies) in pulmonary melanoma metastasis
These data identify Sema7A as a regulator of thalamocortical and local circuit development in layer 4 and provide a molecular handle that can be used to explore the coordinated generation of excitatory and inhibitory cortical circuits.
these results suggest that Sema3A (show SEMA3A Antibodies) and Sema7A have opposite effects and are involved in different stages of synapse elimination.
short hairpin-mediated silencing of SEMA7A reveals roles for semaphorin 7a in the promotion of DCIS growth, motility and invasion as well as lymphangiogenesis in the tumor microenvironment. Our studies also uncover a relationship between COX-2 (show COX2 Antibodies) and semaphorin 7a expression and suggest that semaphorin 7a promotes tumor cell invasion on collagen and lymphangiogenesis via activation of b1-integrin receptor
Our results identified FGL2 (show FGL2 Antibodies), GAL (show GAL Antibodies), SEMA4D (show SEMA4D Antibodies), SEMA7A, and IDO1 (show IDO1 Antibodies) as new candidate genes that could be involved in MSCs-mediated immunomodulation. FGL2 (show FGL2 Antibodies), GAL (show GAL Antibodies), SEMA4D (show SEMA4D Antibodies), SEMA7A, and IDO1 (show IDO1 Antibodies) genes appeared to be differentially transcribed in the different MSC (show MSC Antibodies) populations. Moreover, these genes were not similarly modulated following MSCs-exposure to inflammatory signals
Sema3A (show SEMA3A Antibodies) and sema7A expression correlated with the inflammatory activity of the multiple sclerosis (MS) lesions, suggesting their involvement in the immunological process that takes place in MS.
These results suggest that SEMA7a plays a role as a CSF (show CSF2 Antibodies) biomarkers associated with the conversion to clinically definite multiple sclerosis in clinically isolated syndromes patients
heterozygous missense variants in SEMA3A (show SEMA3A Antibodies) and SEMA7A may modify the phenotype of Kallmann syndrome but most likely are not alone sufficient to cause the disorder
SEMA7A was expressed in the liver and was increased in the course of liver fibrosis, both in mice and in humans.
Semaphorin 7A is a potentially important modulator of eosinophil profibrotic functions in the airway remodeling of patients with chronic asthma.
The protein encoded by this gene binds to cell surfaces through a glycosylphosphatidylinositol (GPI) linkage. The encoded glycoprotein is found on activated lymphocytes and erythrocytes. This protein may be involved in immunomodulatory and neuronal processes. Defects in this gene can result in loss of bone mineral density (BMD). Three transcript variants encoding different isoforms have been found for this gene.
, Semaphorin K1
, sema K1
, sema L
, sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A
, JMH blood group antigen
, John Milton Hagen blood group H-Sema K1
, john-Milton-Hargen human blood group Ag
, sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A (JMH blood group)
, sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, 7A
, semaphorin K1
, semaphorin L
, semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) isoform 1
, semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) isoform 2